title: PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus.
abstract: Pleckstrin homology and leucine rich repeat protein phosphatases (PHLPPs) are a novel class of potent protein kinase B (AKT) inhibitors that have been intensely investigated in relation to AKT activity in cancer. Currently, our understanding of the role of PHLPP1α in the central nervous system is limited. In this study, we characterized PHLPP protein expression and target kinases in the adult hippocampus. We directly verify PHLPP1α inhibits AKT in hippocampal neurons and demonstrate a novel role for PHLPP1β/SCOP, to promote AKT activation. PHLPP1α expression changes dramatically in the hippocampus during development, constituting the most abundant PHLPP protein in adult neurons. Further, while all PHLPP proteins could be observed in the cytosolic fraction, only PHLPP1α could be localized to the nucleus. The results provide unique evidence for a divergence in the function of PHLPP1α and PHLPP1β/SCOP, and suggest that PHLPP1α plays a major role in regulating AKT signaling in neurons.
authors.affiliation: Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida 32610-0244, USA.
authors.forename: Travis C
authors.initials: TC
authors.lastname: Jackson
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Verrier
authors.forename: Susan
authors.initials: S
authors.lastname: Semple-Rowland
authors.forename: Ashok
authors.initials: A
authors.lastname: Kumar
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Foster
mesh_terms: D000375:Aging / Q000235:genetics / Q000502:physiology; D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D005260:Female; D006624:Hippocampus / Q000196:embryology / Q000201:enzymology / Q000502:physiology*; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000502:physiology; D008297:Male; D009474:Neurons / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D009687:Nuclear Proteins / Q000235:genetics* / Q000502:physiology; D010749:Phosphoprotein Phosphatases / Q000235:genetics* / Q000502:physiology; D051571:Protein Kinase C-alpha / Q000378:metabolism / Q000502:physiology*; D051057:Proto-Oncogene Proteins c-akt / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D012326:RNA Splicing / Q000502:physiology; D051381:Rats; D011914:Rats, Inbred BN; D011916:Rats, Inbred F344; D015398:Signal Transduction / Q000235:genetics*
chemical_list: D007527:Isoenzymes; D009687:Nuclear Proteins; D051057:Proto-Oncogene Proteins c-akt; D051571:Protein Kinase C-alpha; C553451:PHLPP1 protein, rat; D010749:Phosphoprotein Phosphatases
references.citation: Cell Death Differ. 2009 Mar;16(3):439-48
references.pmid: 19039330
references.citation: Pharmacol Ther. 2006 Apr;110(1):117-34
references.pmid: 16434104
references.citation: Biol Psychiatry. 2008 Mar 1;63(5):449-57
references.pmid: 17825267
references.citation: J Biol Chem. 2003 Apr 25;278(17):14920-5
references.pmid: 12594205
references.citation: Neurosci Lett. 2009 Dec 18;467(1):30-5
references.pmid: 19800394
references.citation: Dev Cell. 2002 Jun;2(6):831-7
references.pmid: 12062094
references.citation: Mol Vis. 2007 Oct 18;13:2001-11
references.pmid: 17982424
references.citation: Cancer Cell. 2009 Sep 8;16(3):259-66
references.pmid: 19732725
references.citation: Mol Cell. 2010 May 28;38(4):512-23
references.pmid: 20513427
references.citation: Eur J Neurosci. 2005 Mar;21(6):1478-88
references.pmid: 15845076
references.citation: Br J Psychiatry. 2007 Feb;190:156-61
references.pmid: 17267933
references.citation: Eur J Biochem. 1997 Oct 1;249(1):156-60
references.pmid: 9363767
references.citation: Cancer. 2005 Dec 15;104(12):2817-21
references.pmid: 16288491
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3622-7
references.pmid: 18292230
references.citation: Cell Death Differ. 2010 Feb;17(2):324-35
references.pmid: 19745829
references.citation: Mol Cell. 2005 Apr 1;18(1):13-24
references.pmid: 15808505
references.citation: Mol Biol Cell. 2009 Mar;20(5):1533-44
references.pmid: 19144826
references.citation: Mol Cell. 2007 Mar 23;25(6):917-31
references.pmid: 17386267
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):888-94
references.pmid: 20403403
references.citation: Mol Pharmacol. 2002 Aug;62(2):225-33
references.pmid: 12130673
references.citation: Mol Biosyst. 2010 Jan;6(1):38-43
references.pmid: 20024065
references.citation: Annu Rev Pharmacol Toxicol. 2009;49:327-47
references.pmid: 18928402
references.citation: Neurosci Lett. 2008 May 9;436(2):232-4
references.pmid: 18395980
references.citation: J Biol Chem. 2003 Dec 12;278(50):50514-22
references.pmid: 14522959
references.citation: J Biol Chem. 2008 Mar 7;283(10):6300-11
references.pmid: 18162466
references.citation: Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1642-7
references.pmid: 20080691
references.citation: J Biol Chem. 2003 Apr 4;278(14):12361-6
references.pmid: 12517744
references.citation: Cell. 2007 Mar 23;128(6):1219-29
references.pmid: 17382888
references.citation: Neuron. 2009 Sep 24;63(6):761-73
references.pmid: 19778506
references.citation: J Biol Chem. 2009 Aug 14;284(33):22155-22165
references.pmid: 19261608
references.citation: J Biol Chem. 1997 Feb 7;272(6):3544-9
references.pmid: 9013603
references.citation: J Neurochem. 2010 Apr;113(2):477-88
references.pmid: 20089132
references.citation: J Neurosci Res. 1993 Aug 1;35(5):567-76
references.pmid: 8377226
references.citation: Oncogene. 2008 Oct 27;27(50):6473-88
references.pmid: 18955974
references.citation: FEBS Lett. 1999 Sep 24;458(3):363-9
references.pmid: 10570941